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Objective: To investigate the progression of cortical thinning and gray matter volume 
loss in early Parkinson’s disease (PD). 
Methods: Magnetic resonance imaging (MRI) and neuropsychological assessment 
were obtained at baseline and follow-up (mean ± SD = 35.50 ± 1.88 months) in a group 
of 16 early-PD patients (Hoehn and Yahr stage ≤ II and disease duration ≤ 5 years) 
and 15 healthy controls matched for age, gender and years of education. FreeSurfer 
software was used for the analysis of cortical thickness, and for cortical and subcortical 
volumetric analyses. Voxel-based morphometry analysis was performed using SPM8.  
Results: Compared with controls, PD patients showed greater regional cortical 
thinning in bilateral fronto-temporal regions as well as greater over-time total gray 
matter loss and amygdalar volume reduction. PD patients and controls presented 
similar over-time changes in cognitive functioning. 
Conclusion: In early-PD patients, global gray matter loss, amygdalar atrophy and 
cortical thinning in fronto-temporal regions are specifically associated with the PD 
degenerative process.  
 






Cognitive dysfunctions appear early in the course of Parkinson’s disease (PD). 
Cross-sectional, community-based studies have reported impairments in executive 
functions (1,2), attention and psychomotor speed (3,4), memory (1-4), visuospatial 
functions (3) and verbal fluency (1,2) in newly-diagnosed PD patients. Furthermore, 
longitudinal assessment of cognition in these early-PD patients shows a faster rate of 
cognitive decline than in control subjects (5,6). 
According to the neuropathological Braak stages (7), alpha-synuclein pathology 
ascends from the brainstem and olfactory bulb, in the early stages, to the midbrain and 
diencephalic nuclei, and later to the neocortex. However, magnetic resonance imaging 
(MRI) findings do not fully conform to this neuropathological staging. Cross-sectional 
imaging studies in early PD, using different methodological approaches, have found 
highly variable, and usually not extensive, patterns of structural degeneration. 
Specifically, voxel-based morphometry (VBM) and volumetric techniques comparing 
early-PD patients and matched controls have shown white matter (WM) loss in the 
brainstem (8) and GM loss in the striatum (9), amygdala (10) and orbitofrontal cortex 
(OFC) (10). Cortical thickness (CTh) studies, on the other hand, have described focal 
cortical thinning in the OFC, ventrolateral prefrontal cortex, occipito-parietal cortex (9) 
and in the supplementary motor area (11). These discrepant findings highlight the need 
for longitudinal studies using comprehensive techniques to help clarify the typical 
patterns of evolution of structural changes that take place early in Parkinson’s disease.  
The relationship between structural MRI changes and neuropsychological 
deficits in Parkinson’s disease has not been extensively investigated, and the only 
available results come from cross-sectional studies (12). PD patients with mild 
cognitive impairment have been found to have fronto-temporal neocortical reductions 
compared with PD patients with normal cognition (13), and memory deficits have been 
seen to correlate with the degree of hippocampal atrophy (14-16). Similarly, 





parieto-temporal gray matter reductions (17), between verbal fluency and frontal and 
temporal cortical atrophy (18). Specifically for early PD, Ibarretxe-Bilbao et al. (2009) 
showed amygdalar and bilateral OFC degeneration associated with impaired 
recognition of emotions, and GM volume loss in left lateral OFC related to decision-
making impairment (10). 
 VBM and cortical thickness analyses are sensitive to different though 
overlapping GM parameters that are altered in neurodegenerative processes: VBM 
provides a mixed measure of cortical GM, including cortical surface area and/or cortical 
folding as well as cortical thickness (19), whereas cortical thickness analysis has the 
advantage of providing a quantitative value that represents a physical property of the 
cortical mantle. These MRI techniques are considered to provide complementary 
information in different research settings (20-22). 
To our knowledge, no published MRI studies have focused on the progression 
of brain changes using cortical thickness and VBM analyses in early Parkinson’s 
disease. Indeed, longitudinal MRI studies have only been carried out at more advanced 
disease stages, showing progressive ventricular dilation (23,24) and progressive 
cerebral GM loss in non-demented PD (25,26), PD patients at risk for dementia 
(patients with visual hallucinations) (27) and in patients with PD dementia (26,28).  
In the present study, we have performed a prospective assessment of a group 
of early-PD patients and a matched control group of healthy subjects. Subjects 
underwent MRI and neuropsychological assessment both at study entry and after a 
mean follow-up interval of 35.5 months. In a previous study, we reported MRI findings 
at baseline showing GM volume loss in the amygdala and the OFC in early-PD patients 
(10) using a region-of-interest VBM approach. In the current study, we aimed to make a 
global assessment of the brain changes that take place over time in the early stages of 
PD using cortical thickness analysis, whole-brain VBM and volumetric analysis of the 





cognitive changes over time to establish whether these brain MRI measures 




Patients were recruited from an outpatient movement disorders clinic 
(Parkinson’s Disease and Movement Disorders Unit, Department of Neurology, 
Hospital Clinic, Barcelona). Healthy subjects were recruited from friends and spouses 
of patients and matched for age, gender and years of education. At baseline, 24 early-
PD patients and 24 healthy subjects matched for age, gender, and years of education 
participated in the study (the same sample used in the study by Ibarretxe-Bilbao et al., 
2009 (10)). After a mean interval of 35.50 months (SD = 1.85; range 31-40 months), 16 
PD patients and 15 healthy controls from this initial sample participated in the follow-up 
assessment. There were no significant differences between groups in terms of age, 
gender and education. Demographical data of the participants at baseline examination 
is summarized in table 1.   
At the time of initial evaluation (baseline evaluation), the inclusion criteria for 
participating in the study were: i) fulfillment of the UK PD Society Brain Bank (PDSBB) 
diagnostic criteria for PD (29); ii) Hoehn and Yahr stage ≤ II; iii) disease duration ≤ 5 
years. Motor symptoms were assessed by means of the UPDRS-III motor section.  
Exclusion criteria were: i) presence of dementia diagnosed by a neurologist according 
to the Movement Disorder Society diagnostic criteria for Parkinson’s disease dementia 
(30); ii) presence of other neurological or psychiatric disorders such as depression, 
defined by a Beck’s Depression Inventory (BDI-II) score higher than 14 (31); and iii) the 
presence of visual hallucinations assessed by the Neuropsychiatric Inventory 
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  The neuropsychological assessment included the cognitive functions usually 
impaired in PD. The tests used were: forward and backward digit span from the 
Wechsler Adults Intelligence Scale (WAIS-III) as measures of immediate and working 
memory respectively; ii) verbal memory with Rey’s Auditory Verbal Learning Test 
(RAVLT) as a measure of declarative memory; iii) phonemic and semantic fluencies; iv) 
psychomotor speed and inhibition control with the Stroop test; and v) visuomotor 
tracking and cognitive flexibility with the Trail Making test (TMT) (parts A and B). The 
neuropsychological battery was administered by a trained neuropsychologist (N.I-B), 
and completed in a single session lasting between one and two hours. The 
neuropsychologist in charge of the assessment was the same at baseline and follow-up 
examinations. 
 
Neuropsychological and clinical statistical analysis 
Statistical analyses of neuropsychological and clinical variables were carried out 
using the statistical package PASW-18 (SPSS, Inc., 2009, Chicago, 
IL, www.spss.com). Changes in clinical and neuropsychological variables between 
baseline and follow-up were analyzed using the general linear mixed model (GLM) for 
repeated measures to test whether these variables differed across time between 
groups. A two-factor repeated-measures analysis of variance (2x2) (RMANOVA) was 
performed for each of the variables. Factors were: group (PD patients and controls) 
and time (baseline and follow-up). Since groups were matched – there were no 





not included in the model. The interval between neuropsychological assessments in 
months, on the other hand, was entered as a covariate in the RMANOVA. 
 
MRI acquisition 
Structural images at baseline and follow-up were acquired using a MAGNETOM 
Tim Trio 3T scanner (Siemens, Germany). High-resolution 3-dimensional T1-weighted 
images were acquired in the sagittal plane with an MPRAGE sequence (TR/TE 
2300/2.98 ms; TI 900ms; 256×256 matrix, 1mm isotropic voxel). 
 
Cortical thickness analysis 
Cross-sectional evaluation (to determine whether PD patients and controls 
regionally differ in cortical thickness at baseline) and longitudinal analysis (to compare 
CTh between the two timepoints (baseline and follow-up)) were performed using 
FreeSurfer (version 5.1, available at: http://surfer.nmr.harvard.edu). In this procedure, a 
cortical surface three-dimensional model of CTh is created using intensity and 
continuity information previously described in detail (33). The initial processing of T1 
high-resolution images includes several steps, which are performed independently for 
each subject and each timepoint: removal of non-brain tissue (34), automated 
Talairach transformation, intensity normalization (35), tessellation of the gray 
matter/white matter boundary, automated topology correction (36,37), and surface 
deformation to optimally place the gray matter/white matter and gray 
matter/cerebrospinal fluid boundaries (33). The resulting representation of cortical 
thickness is calculated as the distance between tissue boundaries (gray matter/white 
matter and gray matter/cerebrospinal fluid) (33). All surface models in our study were 
visually inspected for accuracy. 
Subsequently, for the longitudinal processing, an unbiased within-subject 
template space and average image (38) is created using robust, inverse consistent 





transformations, atlas registration as well as spherical surface maps and 
parcellations are then initialized with common information from the within-
subject template, significantly increasing reliability and statistical power (40). 
Finally, both time points and the template are used to create the complete subjects 
directories named long run. Regional differences between groups (patients and 
controls) in cortical measures were assessed using vertex-by-vertex general linear 
model (one factor with two levels without covariates, corresponding to a Student’s t-test 
statistical model). Maps were smoothed using a circularly symmetric Gaussian kernel 
across the surface with a FWHM of 15 mm. Z Monte Carlo simulations with 10,000 
iterations were applied to CTh maps to provide clusterwise correction for multiple 
comparisons (41), and results were thresholded at a corrected p value of 0.05 (Z = 
1.3).  In order to perform main longitudinal analyses, we automatically obtained a 
measure of change from longitudinal data called rate of thinning (mm/year). 
Mean rates of thinning for significant clusters were then extracted for each 
subject in order to perform correlational analyses with cognitive measures.  
We used the same methodology to perform complementary analyses with other 
longitudinal measures: the temporal average (the average thickness between baseline 
and follow-up), the percent change (the rate of thinning divided by the baseline 
thickness), and the symmetrized percent change (the rate of thinning divided by the 
average thickness).  
 
Volumetric analysis of subcortical structures  
The automated procedure for volumetric measures of brain structures 
implemented in FreeSurfer (version 5.1, available at: http://surfer.nmr.harvard.edu) (42) 
was used to obtain the volumes of subcortical structures. Volumetric measures were 
automatically obtained from 7 GM structures (thalamus, caudate, putamen, pallidum, 
nucleus accumbens, hippocampus, amygdala), as well as from the lateral, third and 





“subcortical structures” although, strictly speaking, hippocampus and amygdala are not 
subcortical. Total cortical volume, total subcortical volume and global gray matter 
volume were also obtained.  
All the volumes obtained were compared using PASW-18. Repeated measures 
analysis of variance was used to longitudinally examine changes in deep gray matter 
structures, brainstem, ventricles and total GM volumes. Scan number was specified as 
a within-subject factor “time” with two levels (baseline and follow-up MRI acquisitions), 
and a between-subject factor “group” with two levels (PD patients and healthy 
controls). All the volumetric analyses controlled for intracranial volume (ICV). No other 
covariables were included in the model. Partial correlation analyses were performed 
between change in brain volumes and cognition, also controlling for ICV.  
 
Voxel based morphometry analysis 
Image preprocessing for voxel-based morphometry analyses was done using 
SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/). After realignment, baseline 
images were rigidly co-registered to the respective subject’s follow-up image. All 
images were then segmented into GM, WM and cerebrospinal fluid probability maps 
with the New Segment tool of SPM8, an extended version of the 
“Unified Segmentation” model (43).  
In an attempt to obtain an accurate subject registration and consequently an 
adequate detection of within-subject longitudinal changes, subject-specific templates 
were created using the Diffeomorphic Anatomical Registration Through Exponentiated 
Lie algebra (DARTEL) (44) tool to non-linearly register each subject’s GM and WM 
baseline and follow-up images. Baseline and follow-up scans were subsequently 
normalized to their respective template, using the Jacobian determinants for 
modulation. A group template was then created using the baseline GM and WM 
images (normalized to the individual template) of the entire sample, also through 





time to the group template, again applying the Jacobian determinants for modulation. A 
third normalization was performed to bring each subject’s baseline and follow-up GM 
images to the MNI space using an affine transformation, and then smoothed with a 
Gaussian kernel of 12 mm full-width at half-maximum. Final voxel dimension was 1.5 
mm isotropic. A similar preprocessing approach was recently proposed by Asami et al. 
(45). 
The final GM maps generated as described above were analyzed in a whole-
brain voxelwise fashion. For cross-sectional baseline intergroup comparisons, images 
were entered into a two-sample t test model. For longitudinal analysis, subjects’ images 
were entered into a full-factorial model with two factors (the two levels in the group 
factor were entered as independent, and the two levels in the time factor as non-
independent variables, with assumed unequal variance) to evaluate possible group x 
time interactions in GM volume.  
Total intracranial volume (obtained through the sum of the native GM, WM and 
cerebrospinal fluid maps) was entered as a covariate of no interest in all these 
analyses. Subjects’ interscan interval (in months) was also entered as a covariate of no 
interest in the interaction analyses. 
Results were corrected for multiple comparisons using familywise-error 




Neuropsychological tests and clinical variables 
In PD patients, LEDD, Hoehn and Yahr, and UPDRS-III motor section scores 
did not differ significantly between baseline and follow-up assessments (see table 2). 
The analysis of variance for repeated measures revealed a significant time 
effect on MMSE and depression scores but no significant interactions between groups 





decline did not differ between groups. NPI-Q scores remained stable over time in both 
groups.  
At baseline, PD patients showed worse cognitive performance than controls. 
There were significant differences in neuropsychological variables measuring working 
memory (backward digits, t = 3.015, p = 0.005), psychomotor speed (Stroop colors, t = 
2.755, p = 0.010 and words-colors, t = 2.417, p = 0.023) and cognitive flexibility (TMTB, 
t = -2.146, p = 0.046). The longitudinal analyses also showed a significant group effect 
in working memory (digit span backward), psychomotor speed (Stroop colors) and 
cognitive flexibility (TMTB). A significant time effect was seen for psychomotor speed 
assessed by the Stroop test (Stroop words). The only other cognitive variable for which 
a time effect was observed was phonemic fluency, as a result of both groups improving 
their performance at follow-up, suggesting a practice effect. There was no significant 
interaction between time and group for any of the variables analyzed (see table 3). 
 
Cortical thickness 
At baseline, there were no significant differences in cortical thickness between 
PD patients and the healthy control group (data not shown). However, rate-of-thinning 
(mm/year) analyses showed that PD patients had significantly greater progressive 
cortical thinning in the following areas than healthy controls at the corrected level 
(p<0.05) (see figure 1 and table 5):  
- Right superior frontal gyrus, extending to caudal middle frontal gyrus, precentral 
sulcus and precentral gyrus; 
- Right frontal pars opercularis and precentral gyrus; 
- Right superior temporal gyrus extending to the adjacent temporal sulcus; 
- Left caudal middle frontal gyrus extending to rostral middle frontal gyrus and 
precentral region; 





At a more conservative correction level (p<0.01), clusters in the right hemisphere 
remained significant: in the caudal middle frontal gyrus (621.2 mm2; x, y, z Talairach 
coordinates of the maximum: 29.5, 7.5, 47.3) and in the superior temporal gyrus (two 
clusters, one with 549.2 mm2; x, y, z Talairach coordinates of the maximum: 43.9, -4.2, 
-16.2; and the other with 494.4 mm2; x, y, z Talairach coordinates of the maximum: 
63.1, -31.1, 5.6). The complementary longitudinal measures analyzed showed no 
significant group differences in the measure temporal average. However, the measures 
percent change and symmetrized percent change showed patterns of thinning in frontal 
and temporal regions similar to those obtained by means of the rate of thinning (see 
Supplementary Figure 1 for the results of the symmetrized percent change).  
There were no significant correlations between cognitive measures and mean rate 
of thinning (or between cognitive measures and the complementary longitudinal 
measures analyzed) in the clusters described above. 




Table 4 shows total gray matter, total cortical and subcortical gray matter 
volumes (total and by structure) as well as ventricular volumes at baseline and follow-
up. At baseline, there were no significant group differences in volumetric measures 
(data not shown). The loss from baseline to follow-up in subcortical deep gray matter 
structures besides the amygdalae was similar in both groups. We also observed a 
similar volume increase in the ventricular system in both groups. 
Total GM volume reduction over time was greater in PD patients than in healthy 
controls; the time-group interaction was significant. Finally, PD patients also showed 
specific and significant loss in amygdalar and total cortical volumes (see table 4). Total 





(r = 0.541, p = 0.037). Neither amygdalar volume changes nor total cortical volume 
reduction correlated with cognitive changes. 
 
Voxel-based morphometry 
No significant group differences in GM volume were found between healthy 
controls and PD patients at baseline in whole-brain analyses. Interaction analysis did 
not reveal any areas of differential GM loss across groups at the corrected level.  
For exploratory purposes, we report the results without correction for multiple 
comparisons – at the uncorrected level, two clusters of greater GM volume loss in PD 
patients than in controls were observed: in the left inferior lateral occipital cortex (3.08 
cm3; x, y, z MNI coordinates of the maximum: -22, -90, -2; p < 0.001, uncorrected)  and 
in the left angular gyrus (0.37 cm3; x, y, z MNI coordinates of the maximum: -34, -56, 
26; p < 0.001, uncorrected). We did not find any areas of significantly greater GM 
volume loss in healthy controls than in PD patients. 
 
DISCUSSION  
In this longitudinal study, we have found that, compared with controls, our 
sample of early-PD patients presented a faster rate of cortical thinning with a bilateral 
fronto-temporal pattern, total gray matter and total cortical volume loss, and amygdalar 
atrophy after an average interval of 35 months.  
The first longitudinal studies in PD only evaluated global brain measures (25) or 
a limited number of GM areas (28). Since then, longitudinal progression of PD has 
been evaluated in samples formed by older patients, and with patients who had longer 
disease duration. In a previous work done by our group, after a follow-up of 25 months, 
GM loss was observed in limbic and paralimbic structures (26). In another study, 
including patients with visual hallucinations, we also found limbic and paralimbic plus 
neocortical GM loss (27). In this work we also observed that the longitudinal GM loss 





To our knowledge, this is the first study to evaluate structural progressive 
changes in a cohort of early-Parkinson’s disease patients. Our findings indicate that the 
degeneration of certain areas observed in other studies may not yet be detectable in 
non-demented, early-PD patients. The fact that our cohort was formed by younger 
patients could also be contributing to the absence of detectable atrophy in areas 
affected both by the disease and by the aging processes, such as the hippocampus 
(47), as these two factors are considered to interact biologically in the process of 
neuronal cell loss in non-dopaminergic structures (48).  
In the present study, PD patients presented lower scores in some cognitive 
functions compared to controls at baseline, but both groups progressed at the same 
rate of cognitive decline over time. Previous studies reported that longitudinal changes 
in neuropsychological test results in early PD are much more significant in older 
patients (5). This observed interaction both between age and cognitive decline in PD 
could be the functional manifestation of the interaction between age-related and the 
disease-related GM atrophy observed, though this remains speculative. 
In Lewy-body diseases, cognitive changes are expected to precede detectable 
structural changes (49) and we have found greater structural, but no greater cognitive, 
over-time deterioration in PD patients compared with controls. A growing body of 
evidence, however, suggests that cognitive deficits in PD have two general 
pathophysiological bases: fronto-striatal deficits, common in the early stages of 
disease, related to dopaminergic activity and not associated with a higher risk of 
evolution to dementia; and deficits with a more posterior cortical basis, which herald 
further cognitive decline (5,50), and which are possibly related to primary cortical Lewy-
body or Alzheimer-type pathology (51). Indeed, at baseline, our sample of PD patients 
presented deficits in neuropsychological functions related to dopamine-modulated 
circuits, such as working memory (52,53), cognitive flexibility (53,54) and psychomotor 
speed (55). It is not surprising that deficits with a more functional basis might not be 





longitudinally, on the other hand, could be related to the second mechanism of 
cognitive decline described above, and compensatory processes in this sample of 
young, early-PD patients might be preventing detectable functional repercussions.  
 Cross-sectional structural MRI studies with early-PD patients, as pointed in the 
introduction of the current article, show highly variable results, sometimes with limited 
or no significant gray matter changes in comparison with controls (8). One study, 
nonetheless, did find cortical changes in early-stage patients through cortical thickness 
analysis (9). In it, thickness reductions were observed in frontal areas similar to the 
ones we have found to degenerate more rapidly in PD patients than in controls.  
 Overall these results suggest that the different parameters evaluated provide 
complementary and related information on changes occurring in PD.  
A common drawback in longitudinal studies is the loss of some of the initial 
subjects at follow-up. In this study, the final sample of 16 PD patients, though 
appropriate for longitudinal analyses, does not allow dividing them into subgroups to 
study relevant variables such as the presence of dyskinesias, previously related to 
changes in the right inferior frontal gyrus (56) or behavioral abnormalities. Also, we 
cannot exclude that subtle cognitive decline associated with the longitudinal structural 
changes described could be detected with a larger sample. 
One caveat in both VBM and CTh analysis is that, due to the characteristics of 
the underlying neuroanatomy, gray matter and cortical thickness maps are non-
stationary (57). This in turn may lead to an overestimation of cluster sizes in areas of 
the images that display higher smoothing, and an underestimation in rougher areas 
(58), affecting both the false-positive and false-negative rates of analyses that include 
cluster-size corrections (59). Though cluster-size inference methods to correct for 
these effects are sometimes used in VBM analyses (60,61), the permutation cluster-
level correction implemented in cortical thickness analyses assumes images to be 





In conclusion, as in other neurodegenerative diseases such as AD, our findings 
suggest that the pathophysiological process of PD exerts specific deleterious effects in 





Figure 1. Cortical areas showing significantly higher rate of thinning (mm/year) in PD 
patients compared with controls.  
The color bar indicates the significance levels in the clusters of significantly higher 
thinning rate in PD patients than in healthy controls, in Z values. Results were obtained 
using Z Monte Carlo simulation with 10,000 iterations applied to CTh maps to provide 
clusterwise correction for multiple comparisons. Results were thresholded at a 
corrected p value of 0.05 (Z = 1.3). 
 
 
Supplementary Figure 1. Cortical areas showing significantly higher symmetrized 
percent change (SPC, in percentage per year) in PD patients compared with controls.  
 
The color bar indicates the significance levels in the clusters of significantly higher SPC 
in PD patients than in healthy controls, in Z values. Results were obtained using Z 
Monte Carlo simulation with 10,000 iterations applied to CTh maps to provide 
clusterwise correction for multiple comparisons. Results were thresholded at a 
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Table 1. Demographical data at baseline. 
 PD (n=16) Controls (n=15) ta, χb p 




Gender (male/female) 12/4 12/3 0.111b 0.539 




Age onset 52.97 (8.24) - - - 
Disease duration (years) 2.97 (1.45) - - - 
 
Values are mean (SD). PD= Parkinson’s disease. 
a Student’s t-test, b chi-squared test statistics. 
Table 2. Clinical data at baseline and at follow-up and time effect, group effect, 




*Significant at p value < 0.05 
The F values refer to those obtained through a repeated-measures general linear 
model. F(T): time effect; F(G): group effect; F (GxT): Interaction between time and 
group. 
MMSE: Mini-mental state examination; BDI-II: Beck Depression Inventory II; NPI: 
Cumming’s Neuropsychiatric Inventory; UPDRS: Unified Parkinson’s disease rating 












 PD (n=16) Controls (n=15) 
F(T) F(G) F(GxT) 
 Baseline Follow-up Baseline Follow-up 






(0.68) 17.358* 1.185 0.172 






(2.47) 4.440* 3.281 0.035 






(3.58) 0.168 1.099 0.960 
UPDRS-III 15.44 (3.71) 
15.38 






(0.38)   0.285   
LEDD 282.50 (317.98) 
444.38 
(357.50)   0.721   
Table 3. Neuropsychological data at baseline and at follow-up. Time effect, group 




PD (n=16) Controls (n=15) 
F(T) F(G) F(GxT) 
Baseline Follow-up Baseline Follow-up 
Attention, immediate recall and working memory 
Digit span 








(2.29) 0.310 0.617 3.285 









(2.28) 0.890 5.275* 0.029 


























































































(4.90) 1.031 1.661 2.192 






























(8.17) 0.485 1.662 0.266 
 
The F values refer to those obtained through a repeated-measures general linear 
model. F(T): time effect; F(G): group effect; F(GxT): Interaction between time and 
group. 
WM: working memory; RAVLT: Rey’s auditory verbal learning test; SCWT: Stroop 






Visuomotor tracking and cognitive flexibility 






(16.97) 1.387 2.130 0.164 






(25.40) 0.133 5.335* 1.887 




The F values refer to those obtained through a repeated-measures general linear 
model (2x2 MANOVA): group factor (PD and Controls), time factor (baseline and follow-
up). F(T): time effect;  F(G): group effect; F (GxT): Interaction between time and group. 
All the analyses were controlled by intracranial volume. * significant at p < 0.05. 
 
 
 PD (n=16) Controls  (n=15) F (T) F(G) F(GxT) 
 Baseline Follow-up Baseline Follow-up 






(1.41) 0.014 0.004 0.022 






(1.18) 0.883 2.583 0.184 






(1.12) 1.640 1.277 0.855 






(0.41) 0.723 0.017 0.292 






(1.04) 0.046 0.048 1.421 






(0.36) 0.098 0.132 5.661* 






(0.15) 2.559 0.004 0.458 
















(0.57) 0.243 0.218 1.492 






(0.54) 0.698 0.002 0.001 






(0.51) 0.109 1.829 2.964 






(2.58) 3.858 1.055 0.003 
















(16.40) 0.477 0.307 0.007 









(51.72) 4.100 0.002 5.400* 
Table 5. Cortical areas showing significantly higher rates of thinning (mm/year) in PD 
patients compared to controls over time.   




Coordinates of the 
maxima 
x     y    z 
Z  values  Clusterwise 
probability (p) 
Right hemisphere 
Superior frontal gyrus, 
caudal middle frontal 
region, precentral sulcus 
and paracentral region  
2603.88 12.2 -4.5 62.7 3.868 < 0.001 
Frontal pars opercularis, 
precentral gyrus 
1737.77      47.4   12.3  15.3 3.074 0.001 




1197.26  43.9  -4.2 -16.2  5.115 < 0.001 
Left hemisphere 
Caudal middle frontal, 
precentral, rostral middle 
frontal gyrus 
1373.34     -34.6   23.0   43.5   3.100 < 0.005 
Middle temporal gyrus, 
superior temporal gyrus, 
superior temporal 
sulcus, inferior parietal 
lobe 
 
1062.84 -59.4 -49.6 4.1 2.511 0.026 
 
The results were corrected using family wise error correction with Z Monte Carlo 
simulation (10000 iterations) and thresholded at a corrected p value of 0.05 (Z=1.3). 
 
 
 


